MLYS R&D Expenses
Mineralys Therapeutics Inc · R&D Expenses
MLYS R&D Expenses
Latest reported$301.59Mperiod ending
MLYS TTM R&D Expenses ($25.05M → $301.59M)
TTM R&D Expenses
High-resolution chart · PNG
MLYS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 301,594,000 | |
| 118,495,000 | |
| 132,009,000 | |
| 152,176,000 | |
| 174,711,000 | |
| 175,706,000 | |
| 168,581,000 | |
| 147,697,000 | |
| 116,211,000 | |
| 88,822,000 | |
| 70,361,000 | |
| 54,494,000 | |
| 38,054,000 | |
| 31,765,000 | |
| 26,250,000 | |
| 25,048,000 |